Your session is about to expire
← Back to Search
Denosumab Switch for Osteoporosis
Study Summary
This trial is testing whether switching from one medication to another will help people who are taking glucocorticoids and have increased bone turnover markers.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been diagnosed with Addison's disease.I cannot take denosumab due to bad reactions or allergies.I haven't had cancer in the last 5 years, except for certain skin cancers or early-stage cervical cancer.I cannot tolerate or am allergic to zoledronic therapy.You have a history of anorexia nervosa, bulimia, or obvious malnutrition.I have been taking a steroid medication equivalent to more than 7.5 mg of prednisone daily for over 3 months and will continue for at least 6 months.Your liver tests show high levels of certain chemicals.Your blood test shows low levels of vitamin D.My thyroid is overactive and not controlled by medication.I plan to have dental surgery or implants within the next 2 years.My kidney function is severely reduced.My bone density is low, or I've had a fracture due to weak bones.I have been treated with denosumab for over 24 months.I am 18 or older and can give my consent.I cannot take alendronate due to severe side effects or allergy.I have a history of soft bones (osteomalacia).I have a history of Paget's disease of bone.I have had osteonecrosis of the jaw.My thyroid condition is not well-managed.Your calcium levels are significantly lower than the normal range.Your calcium levels are more than 10% higher than the normal range.I plan to try for a child within the next year.I have taken bisphosphonates in the last 2 years.I have had an unusual fracture in my thigh bone.You can't take calcium or vitamin D supplements.Less than three of my lower back bones can be checked with a special X-ray.I have had dental surgery, including tooth extraction or implants, in the last 6 months.I have had a solid organ or bone marrow transplant.I have a bone condition that affects how my bones break down and rebuild.
- Group 1: DMAB to "Early" Zoledronic Acid (ZA)
- Group 2: Denosumab (DMAB) to Alendronate (ALN)
- Group 3: DMAB to "Late" ZA
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this medical experiment currently assembling new participants?
"This clinical trial, which was first advertised on August 17th 2020, is currently accepting enrolment applications. The listing has been updated as recently as December 3rd 2021 according to the data available online."
What is the scope of this research endeavor in terms of participant numbers?
"Affirmative. Clinicaltrials.gov records show that this clinical trial is actively searching for participants, with its initial post on August 17th 2020 and a recent edit on December 3rd 2021. 45 patients will be accepted from 1 medical centre."
Has the FDA approved a comparison between Denosumab and Alendronate?
"Due to this being a phase 4 trial, which implies FDA approval for the treatment, Denosumab (DMAB)'s safety when compared to Alendronate (ALN) has been rated as a 3."
Share this study with friends
Copy Link
Messenger